end of May deadline means nothing. will probably take longer to nut out terms from the interview. the longer it takes the more likely a deal will be signed in my opinion. I think this is a buy short and long term.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
